Recovery Management Intervention in China
|ClinicalTrials.gov Identifier: NCT01270100|
Recruitment Status : Completed
First Posted : January 5, 2011
Last Update Posted : January 5, 2011
The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.
The project has the following specific aims:
Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.
Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.
It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors
|Condition or disease||Intervention/treatment|
|Methadone HIV Infections||Behavioral: Recovery management|
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China|
|Experimental: Recovery management intervention||Behavioral: Recovery management|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01270100
|Shanghai Mental Health Center|